15 million dollar market cap with 5 million in cash for a significant drug, multi billion dollar market and game changer. Going to rally heavily over coming 3-6 months heading into phase 1 studies. AGN was at a 50 million market cap before GLP and 100 million dollar market cap in 2021 on phase 1 studies. Looking very interesting
Ann: Nyrada Commences Key Brain Injury Program Preclinical Study, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $59.05M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 28.0¢ | $43.20K | 150.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 75705 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 15.13pm 18/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |